Cardinal Health (CAH) Stock Price, Fundamentals & Analysis

What CAH does

Cardinal Health (CAH) is a US-based healthcare services and products company that operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. It supplies customised solutions to hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home, distributing branded and generic pharmaceuticals, specialty pharmaceuticals, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products, pharmacy management services to hospitals, operates pharmacies including those in community health centers, and repackages generic pharmaceuticals and over-the-counter healthcare products.

Key numbers explained

• 221.27 USD is the current share price, the amount you would pay for one share at this moment.
• The trailing P/E ratio of 30.6 (price-to-earnings ratio) compares the share price to the last 12 months of earnings per share; a higher number can mean the market expects strong future growth.
• The forward P/E ratio of 15.7 uses expected future earnings, offering a different view of how the market values the company.
• 7.24 USD is the trailing 12-month earnings per share (EPS), showing the portion of profit allocated to each share.
• The dividend yield of 0.93% (dividend yield) tells you the annual dividend as a percentage of the share price; it is a measure of cash return to shareholders.
• 0.52 is the beta, meaning the stock has historically been less volatile than the overall market.
• 51.24B USD is the market capitalisation, the total value of all outstanding shares.
• 254.25B USD in trailing 12-month revenue shows the scale of the company's sales, with a year-over-year growth of 5.8%.

Recent news

• A global medical textile report highlights Cardinal Health among benchmark companies competing for market share in a rapidly growing sector.
• A list of large-cap stocks with solid fundamentals includes Cardinal Health, while another article discusses stocks investors tend to overlook.
• A piece on Cardinal Health's stock movement and another on its MSO expansion both examine potential growth drivers in specialty care delivery.
• Comparative articles position Cardinal Health against peers such as Pfizer (PFE) and UnitedHealth Group (UNH), while a broker consensus piece asks whether it is considered a good investment.

What to watch

• Healthcare policy and reimbursement changes in the US can affect demand for distribution and services.
• Competition from other large healthcare services and distribution companies, including those in the S&P 500, influences market share and margins.
• Specialty care expansion and pharmacy services growth are key strategic areas for companies like Cardinal Health.
• Earnings reports, such as the upcoming one on 5 nov. 2026, often drive short-term price moves.